Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2020
|
P Roy Vagelos Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,439
+1.02%
|
-
|
|
Dec 09
2020
|
Andrew J Murphy EVP Research |
BUY
Grant, award, or other acquisition
|
Direct |
10,214
+8.13%
|
-
|
|
Dec 01
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$51,900
$520.0 P/Share
|
|
Nov 19
2020
|
P Roy Vagelos Director |
BUY
Bona fide gift
|
Indirect |
2,406
+40.0%
|
-
|
|
Nov 19
2020
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
2,406
-4.79%
|
-
|
|
Nov 17
2020
|
Andrew J Murphy EVP Research |
SELL
Open market or private sale
|
Direct |
6,628
-0.69%
|
$3,612,260
$545.61 P/Share
|
|
Nov 16
2020
|
Andrew J Murphy EVP Research |
SELL
Payment of exercise price or tax liability
|
Direct |
7,108
-11.68%
|
$3,987,588
$561.39 P/Share
|
|
Nov 16
2020
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
13,736
+18.41%
|
$412,080
$30.63 P/Share
|
|
Nov 13
2020
|
N Anthony Coles Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11
+1.65%
|
$3,795
$345.47 P/Share
|
|
Nov 02
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.07%
|
$54,800
$548.92 P/Share
|
|
Oct 22
2020
|
Andrew J Murphy EVP Research |
BUY
Exercise of conversion of derivative security
|
Direct |
5,185
+5.34%
|
$212,585
$41.33 P/Share
|
|
Oct 06
2020
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
349
-0.24%
|
-
|
|
Oct 05
2020
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
9,212
-62.01%
|
$5,527,200
$600.0 P/Share
|
|
Oct 05
2020
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,212
+38.28%
|
$4,790,240
$520.01 P/Share
|
|
Oct 05
2020
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-6.68%
|
$600,000
$600.0 P/Share
|
|
Oct 05
2020
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+6.26%
|
$342,000
$342.93 P/Share
|
|
Oct 01
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$55,900
$559.51 P/Share
|
|
Sep 24
2020
|
Christopher R. Fenimore SVP Finance & CFO |
BUY
Bona fide gift
|
Indirect |
50
+50.0%
|
-
|
|
Sep 24
2020
|
Christopher R. Fenimore SVP Finance & CFO |
SELL
Bona fide gift
|
Indirect |
50
-100.0%
|
-
|
|
Aug 20
2020
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,000
-6.68%
|
$612,000
$612.15 P/Share
|
|
Aug 20
2020
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+6.26%
|
$342,000
$342.93 P/Share
|
|
Jul 27
2020
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Bona fide gift
|
Indirect |
57,465
-100.0%
|
-
|
|
Jun 09
2020
|
Sanofi |
SELL
Open market or private sale
|
Indirect |
120,234
-30.06%
|
$71,779,698
$597.48 P/Share
|
|
May 29
2020
|
Sanofi |
SELL
Open market or private sale
|
Indirect |
2,399,552
-85.71%
|
$1,221,371,968
$509.85 P/Share
|
|
May 29
2020
|
Sanofi |
SELL
Open market or private sale
|
Direct |
20,421,899
-100.0%
|
$10,394,746,591
$509.85 P/Share
|
|
May 06
2020
|
Arthur F Ryan Director |
SELL
Bona fide gift
|
Direct |
2,000
-7.59%
|
-
|
|
Mar 09
2020
|
Sanofi |
SELL
Open market or private sale
|
Direct |
128,914
-0.63%
|
$63,038,946
$489.65 P/Share
|
|
Feb 26
2020
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
750
-3.45%
|
-
|
|
Nov 26
2019
|
Arthur F Ryan Director |
SELL
Bona fide gift
|
Direct |
1,000
-3.66%
|
-
|
|
Nov 22
2019
|
Arthur F Ryan Director |
SELL
Bona fide gift
|
Direct |
1,500
-5.2%
|
-
|
|
Sep 10
2019
|
Sanofi |
SELL
Open market or private sale
|
Direct |
172,904
-0.83%
|
$48,586,024
$281.15 P/Share
|
|
Mar 08
2019
|
Sanofi |
SELL
Open market or private sale
|
Direct |
131,115
-0.63%
|
$54,019,380
$412.17 P/Share
|
|
Sep 06
2018
|
Sanofi |
SELL
Open market or private sale
|
Indirect |
104,552
-0.44%
|
$42,448,112
$406.68 P/Share
|
|
Jun 08
2018
|
Sanofi |
SELL
Open market or private sale
|
Indirect |
121,601
-0.51%
|
$37,574,709
$309.31 P/Share
|
|
Aug 25
2017
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
72,378
+0.03%
|
$34,886,196
$482.98 P/Share
|
|
Aug 24
2017
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
105,820
+0.03%
|
$50,899,420
$481.79 P/Share
|
|
Aug 23
2017
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
60,595
+0.05%
|
$28,964,410
$478.3 P/Share
|
|
Jun 02
2017
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
136,050
+0.04%
|
$64,623,750
$475.63 P/Share
|
|
Jan 11
2017
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
87,298
+0.02%
|
$32,387,558
$371.01 P/Share
|
|
Jun 14
2016
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
64,731
+0.04%
|
$23,562,084
$364.22 P/Share
|
|
Feb 17
2016
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
80,000
+0.04%
|
$31,520,000
$394.18 P/Share
|
|
Feb 16
2016
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
81,157
+0.04%
|
$31,651,230
$390.83 P/Share
|
|
Jan 12
2016
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
83,938
+0.02%
|
$38,863,294
$463.51 P/Share
|
|
Oct 06
2015
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
91,578
+0.01%
|
$42,309,036
$462.91 P/Share
|
|
Sep 23
2015
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
147,209
+0.04%
|
$78,315,188
$532.0 P/Share
|
|
Jul 27
2015
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
10,639
+0.0%
|
$5,702,504
$536.74 P/Share
|
|
Dec 24
2014
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
30,002
+0.02%
|
$11,880,792
$396.41 P/Share
|
|
Dec 23
2014
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
171,457
+0.06%
|
$67,039,687
$391.47 P/Share
|
|
Oct 16
2014
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
122,127
+0.05%
|
$40,790,418
$334.12 P/Share
|
|
Oct 15
2014
|
Sanofi |
BUY
Open market or private purchase
|
Indirect |
158,368
+0.06%
|
$52,103,072
$329.35 P/Share
|